News and resources | Resources
Video 24 June 2021

COVID-19 vaccines: Meeting the world’s need (Step #2) Video

By IFPMA
Share
Topics
COVID-19

About IFPMA

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations around the world. Our industry’s almost three million employees discover, develop, and deliver medicines and vaccines that advance global health. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. For more information, visit ifpma.org.

Learn more

Media Contact

Elliot Dunster

Related news and resources

Press release 13 Sep 2023

Ahead of UN General Assembly, pharmaceutical industry underscores need for pandemic preparedness plans to support innovation and equity

Ahead of discussions at the United Nations General Assembly (UNGA78), the trade association representing the innovative pharmaceutical industry, the IFPMA, has warned that current pandemic preparedness plans should not undermine what worked well in response to COVID-19 and must support both “innovation and equity.”

Read more
Statement 9 Jun 2023

First-of-its-kind event brings together 10 companies that partnered to deliver vaccines and treatments in response to COVID-19

On 7 June 2023, IFPMA hosted a unique opportunity to hear from 10 companies, about the different partnership models that supported the industry’s response to COVID-19.  This open event included discussion on the challenges of scaling up manufacturing to meet global demand for vaccines and treatments, with representatives from MSD – Dr Reddy’s Laboratories; Gilead...

Read more
Statement 5 May 2023

Comment on WHO announcement that COVID-19 no longer a Public Health Emergency of International Concern

IFPMA comment on WHO announcement that COVID-19 no longer constitutes a PHEIC.

Read more
Top